All jabs in Hungary shown to prevent serious illness, says medical uni head

A second round of tests of people inoculated against coronavirus has shown that 88 percent have sufficient antibodies to protect them against the virus, Béla Merkely, the dean of Semmelweis University, told public broadcaster M1 on Wednesday, adding, however, that focusing on the level of antibodies as a marker for immunity was beside the point.

“Clinical efficacy is the point in vaccination — the extent to which the jab can protect patients from getting seriously ill,” he said. “By that measure, all vaccines applied in Hungary have shown good results.”

• Unvaccinated millions to cause 4th wave? + Hungary is ready to give a third dose

Fully 1,195 people whose initial tests had indicated zero or a low level of antibodies were tested for a second time, Merkely said.

Positivity in the second round was 97 percent for the Sputnik and AstraZeneca vaccines, 94-97 percent for Pfizer and Moderna, and 82 percent for Sinopharm.

He added that 93 percent of Sinopharm recipients below the age of 60 whose first antibody test was negative showed antibodies second time round, while this was true of 82 percent for those above that age.

The sensitivity of tests vary greatly across laboratories, he said, adding that the US Food and Drug Administration did not recommend that method, either, preferring the measure of clinical efficacy.

Concerning a possible fourth wave of the pandemic, Merkely warned that Hungary’s 3 million unvaccinated were fully exposed to the virus.